AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
10x Science raises $4.8M to use AI for identifying promising drug candidates from vast molecular datasets.
Read on TechCrunch →Jeff Bezos' AI lab, Project Prometheus, is reportedly close to securing $10 billion in funding, valuing the company at $38 billion. Major investors like JPMorgan and BlackRock are involved.
Why it matters
This funding round signifies substantial investor confidence in the potential of AI to revolutionize engineering and manufacturing sectors. The significant valuation suggests that Project Prometheus is perceived as a major player with the capability to develop impactful AI solutions for industrial applications, potentially leading to advancements in efficiency, automation, and product development across various industries.
Jeff Bezos' AI company is getting a lot of money from big investors, making it worth a lot. They are building AI to help make things in factories and other industries better.
10x Science raises $4.8M to use AI for identifying promising drug candidates from vast molecular datasets.
Read on TechCrunch →Google Cloud Next 2026 showcased numerous AI startups leveraging its cloud platform.
Read on TechCrunch →SpaceX is reportedly in talks to acquire AI coding startup Cursor, with an option to buy for $60 billion, highlighting the intense competition and strategic moves in the AI developer tools market.
Read on TechCrunch →